Navigation Links
Minority Biomedical Entrepreneurship Conference
Date:3/19/2012

CLEVELAND, March 19, 2012 /PRNewswire-USNewswire/ -- The nation's first Minority Biomedical Entrepreneurship Conference (MBEC), will convene May 21-22 in Cleveland.  MBEC offers a unique platform for minority professionals, entrepreneurs, investors, students and industry leaders to engage, network, collaborate and exchange ideas.

(Logo: http://photos.prnewswire.com/prnh/20120319/DC71722LOGO)

Minorities represent less than 5 percent(1) of the growing biomedical industry workforce, and a fraction of that number engages in entrepreneurial endeavors. To address the issue of underrepresentation, and to increase minority competitiveness in the biomedical industry, The America21 Project, a minority innovation and competitiveness initiative, and BioEnterprise, a biomedical business accelerator, partnered to created MBEC. The intent is to hold the conference annually.

Keynoting the conference is Dr. Frank Douglas, President of the Austen BioInnovation Institute and former Executive Vice President and Chief Scientific Officer of Aventis.  A national steering committee of Hispanic and African-American leaders in the biomedical industry – including Guy Fish, Vice President Fletcher Spaght Ventures (Boston); Ron Foy, Managing Director Cambria Capital (San Francisco); and Marissa Trevino, Founder Latina Lista (Dallas)- guide the conference mission and direct the agenda.   A nationally-recognized speaker line-up – including Dr. William L. Daley, Vice President Business Development & Licensing, U.S. Medical Affairs, Sanofi (New Jersey); and Monica Sturgis, HR Business Partner, Boehringer-Ingelheim (Cleveland) – complete an inspired conference agenda.

"Cleveland, with its rapidly growing biomedical industry and nationally recognized research, clinical and educational institutions, is the ideal location for the first-ever Minority Biomedical Entrepreneurship Conference," said Baiju R. Shah, President and CEO of BioEnterprise and Co-Chair of MBEC.  "The entrepreneurial environment  is one that embraces and provides an unparalleled support network to biomedical innovators."  

The Minority Biomedical Entrepreneurship Conference tackles many challenges minorities face in the biomedical industry. Attendees will be offered mentoring opportunities with industry leaders and investors, entrepreneurship education, and practical advice on starting and growing a biomedical company. Entrepreneurs looking for funding are afforded the opportunity to present before a group of seasoned biomedical investors. To view the complete conference agenda and register, visit http://www.minoritybiomedical.org.

"The underrepresentation of African Americans and Latinos in the biomedical industry undermines national economic competitiveness," said Johnathan Holifield, a co-founder of The America21 Project and co-chair of MBEC. "MBEC confronts the problem by bringing minority entrepreneurs together with industry veterans and investors for mentoring, networking and education."

About The America21 Project:

America21, the first and only national voice for accelerating the growth of African American and Latino American prosperity through increased innovation capacity and economic competitiveness, has partnered with innovation ecosystem leadership organizations to seed Inclusive Competitiveness in Northeast Ohio and is similarly partnering with other regional innovation-based economic development organizations in additional urban regions, including Portland OR and Pittsburgh, PA. To learn more about The America21 Project, visit www.blackinnovation.org.

About BioEnterprise:

BioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to health care companies.

BioEnterprise partners are Case Western Reserve University, Cleveland Clinic, University Hospitals, Summa Health System, and the BioInnovation Institute in Akron.  Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech, and BioOhio.  The initiative comprises the collective activities of BioEnterprise and its partners' commercialization offices:  the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center - Center for Clinical Research and Summa Enterprise Group.  The combined efforts of these groups has created, recruited, and accelerated more than 100 companies in nine years. For more information see www.bioenterprise.com

(1) Diversity in Academic Biomedicine: An Evaluation of Education and Career Outcomes with Implications for Policy, Donna K. Ginther, Professor, Department of Economics, University of Kansas, September 22, 2009.


'/>"/>
SOURCE BioEnterprise Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. HumanTouch Founder, President and CEO, Moe Jafari Named Washington Business Journal Minority Business Leader Honoree
2. Ohio Capital Fund Announces Sponsorship of Minority Business Conference
3. ECBC Now Accepting Applications for 2009 Minority Undergraduate Summer Internship Program
4. ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.
5. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
6. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
7. Live Press Briefing on Findings of Biomedical Industry CEO Survey
8. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
9. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
10. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
11. Saladax Biomedical, Inc. Appoints Li Zhang, M.D., to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , Jan. 24, 2017  Asterias Biotherapeutics, Inc. ... field of regenerative medicine, today announced positive efficacy ... clinical trial that showed additional motor function improvement ... million AST-OPC1 cells in AIS-A patients with complete ... of upper extremity motor function is critically important ...
(Date:1/24/2017)... Switerland (PRWEB) , ... January 24, 2017 , ... ... first commercially available malaria Plasmodium falciparum culture panels with standard concentrations of histidine ... which are available in a range of concentrations from six different malaria strains, ...
(Date:1/24/2017)... , ... January 23, 2017 , ... Oklahoma City based ... newest client for the firm’s PERFEQTA software and legacy product QC Manager 2.0. ... the dynamic team at CJBC and thrilled that they have decided to implement PERFEQTA ...
(Date:1/24/2017)... , Jan. 23, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... into an underwriting agreement with Rodman & Renshaw, a ... as sole book running manager and representative of several underwriters, ... a firm commitment basis a minimum of 2,105,264 shares ... to purchase a minimum of 1,052,632 shares of common ...
Breaking Biology Technology:
(Date:1/18/2017)... -- In vitro diagnostic (IVD) companies were very active in ... Kalorama Information expects that trend to continue – though ... uncertainty in reimbursement and healthcare reform in ... acquisitions landscape. Instead of looking to buy technology, the ... of their home country and also to increase their ...
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
(Date:1/6/2017)... LA JOLLA, Calif. , Jan. 6, 2017 ... Phase 1 safety studies in healthy volunteers of ... CM4620, intended to treat acute pancreatitis. ... pancreas, is typically a mild disorder, but can ... to organ failure and sepsis, where extended hospital ...
Breaking Biology News(10 mins):